SEER, INC. Stock-Based Compensation
SEER, INC. (SEER) reported Stock-Based Compensation of $3.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- SEER, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.56M, a 59.61% decline year-over-year.
- SEER, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.13M, a 54.39% decline year-over-year.
- SEER, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.29M, a 48.97% decline year-over-year.
- SEER, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.59M, a 44.92% decline year-over-year.
- SEER, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $15.41M, a 45.35% decline from fiscal 2024.
- SEER, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $28.21M, a 18.06% decline from fiscal 2023.
- SEER, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $34.42M, a 2.23% increase from fiscal 2022.
- SEER, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $33.67M, a 29.88% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.69M 10-Q · filed 2026-08-11 | $6.98M derived: sum of 3 quarters · filed 2026-08-11 | $10.57M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $2.13M 10-Q · filed 2026-05-13 | $5.41M derived: sum of 2 quarters · filed 2026-05-13 | $9.01M derived: sum of 3 quarters · filed 2026-05-13 | $12.88M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $6.88M derived: sum of 2 quarters · filed 2026-03-02 | $10.75M derived: sum of 3 quarters · filed 2026-08-11 | $15.41M 10-K · filed 2026-03-02 |
| 2025-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.46M derived: sum of 2 quarters · filed 2026-08-11 | $12.13M 10-Q · filed 2025-11-06 | $18.57M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $3.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $8.54M 10-Q · filed 2026-08-11 | $14.97M derived: sum of 3 quarters · filed 2026-08-11 | $21.50M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $4.66M 10-Q · filed 2026-05-13 | $11.10M derived: sum of 2 quarters · filed 2026-05-13 | $17.63M derived: sum of 3 quarters · filed 2026-05-13 | $25.29M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $12.96M derived: sum of 2 quarters · filed 2026-03-02 | $20.63M derived: sum of 3 quarters · filed 2026-03-02 | $28.21M 10-K · filed 2026-03-02 |
| 2024-09-30 | $6.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.19M derived: sum of 2 quarters · filed 2025-11-06 | $21.77M 10-Q · filed 2025-11-06 | $29.38M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $7.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $15.24M 10-Q · filed 2025-08-06 | $22.86M derived: sum of 3 quarters · filed 2025-08-06 | $31.19M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $7.58M 10-Q · filed 2025-05-13 | $15.19M derived: sum of 2 quarters · filed 2025-05-13 | $23.53M derived: sum of 3 quarters · filed 2025-05-13 | $33.28M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $15.95M derived: sum of 2 quarters · filed 2025-03-03 | $25.70M derived: sum of 3 quarters · filed 2025-03-03 | $34.42M 10-K · filed 2025-03-03 |
| 2023-09-30 | $8.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $18.09M derived: sum of 2 quarters · filed 2024-11-06 | $26.81M 10-Q · filed 2024-11-06 | $34.97M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $9.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $18.48M 10-Q · filed 2024-08-08 | $26.64M derived: sum of 3 quarters · filed 2024-08-08 | $35.71M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $8.72M 10-Q · filed 2024-05-08 | $16.88M derived: sum of 2 quarters · filed 2024-05-08 | $25.96M derived: sum of 3 quarters · filed 2024-05-08 | $34.34M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $17.23M derived: sum of 2 quarters · filed 2024-03-04 | $25.61M derived: sum of 3 quarters · filed 2024-03-04 | $33.67M 10-K · filed 2024-03-04 |
| 2022-09-30 | $9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $17.45M derived: sum of 2 quarters · filed 2023-11-07 | $25.51M 10-Q · filed 2023-11-07 | $32.18M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $8.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $16.44M 10-Q · filed 2023-08-08 | $23.11M derived: sum of 3 quarters · filed 2023-08-08 | $29.90M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $8.06M 10-Q · filed 2023-05-09 | $14.73M derived: sum of 2 quarters · filed 2023-05-09 | $21.52M derived: sum of 3 quarters · filed 2023-05-09 | $27.95M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $13.46M derived: sum of 2 quarters · filed 2023-03-06 | $19.89M derived: sum of 3 quarters · filed 2023-03-06 | $25.93M 10-K · filed 2023-03-06 |
| 2021-09-30 | $6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $13.22M derived: sum of 2 quarters · filed 2022-11-08 | $19.26M 10-Q · filed 2022-11-08 | $24.04M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $6.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $12.47M 10-Q · filed 2022-08-09 | $17.25M derived: sum of 3 quarters · filed 2022-08-09 | $18.43M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $6.04M 10-Q · filed 2022-05-06 | $10.82M derived: sum of 2 quarters · filed 2022-05-06 | $12.00M derived: sum of 3 quarters · filed 2022-05-06 | $12.81M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.96M derived: sum of 2 quarters · filed 2022-03-01 | $6.77M derived: sum of 3 quarters · filed 2022-03-01 | $7.35M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.99M derived: sum of 2 quarters · filed 2021-11-09 | $2.56M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $808.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.39M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $579.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |